Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Citi: GALAXY ENT (00027.HK) 3Q Results in Line
Recommend 15 Positive 26 Negative 12 |
||||
|
||||
|
GALAXY ENT (00027.HK)'s 3Q25 results were in line with expectations, with quarterly net revenue increasing by 14% YoY or 1% QoQ to $12.163 billion, Citi Research issued a research report saying. Adjusted EBITDA grew by 14% YoY (but decreased by 6% QoQ) to $3.341 billion, approx. 3% higher than the broker's forecast of $3.244 billion, broadly in line with market consensus of $3.321 billion. Citi Research estimated its market share to be flat QoQ at about 20.2%. Adjusted EBITDA margin fell by 0.1 ppt YoY (2.2 ppts QoQ) to 27.5%, ahead of the broker's forecast of 26.5%. Therefore, the broker rated GALAXY ENT at Buy, with a target price of $54. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
